In particular, activation of PI3K/AKT pathway in NSCLC has been associated with increased cellular survival and resistance to chemotherapy and radiation, two important clinical problems encountered in several cancers [29]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.